Ruvax Vet. injektionsvæske, suspension 25 IE/ml
Ruvax Vet. injektionsvæske, suspension 25 IE/ml
Not authorised
- Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Product identification
Medicine name:
Ruvax Vet. 25 IE/ml injektionsvæske, suspension
Ruvax Vet. injektionsvæske, suspension 25 IE/ml
Active substance:
- Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Erysipelothrix rhusiopathiae, serotype 2, Inactivated1.00/enzyme-linked immunosorbent assay unit2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Denmark
Package description:
- Available only in Danish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Denmark A/S
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
- MERIAL Laboratoire Porte des Alpes
Responsible authority:
- Danish Medicines Agency
Authorisation number:
- 14967
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Danish (, INJEKTIONSVÆSKE, SUSPENSION 25 IE-ML)
Published on: 26/05/2022